Explore more publications!

Superior Group of Companies Reports Fourth Quarter 2025 Results

– Total net sales of $146.6 million versus $145.4 million in prior year fourth quarter 
– Net income of $3.5 million versus $2.1 million in prior year fourth quarter 
– EBITDA of $8.6 million versus $7.3 million in prior year fourth quarter –
– Provides full-year outlook –
 

ST. PETERSBURG, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its fourth quarter 2025 results.

“We finished the year with a solid fourth quarter, growing our consolidated revenues while simultaneously reducing expenses which resulted in 19% year-over-year EBITDA growth and earnings per share that nearly doubled,” said Michael Benstock, Chief Executive Officer.  “In addition, our quarterly results again demonstrated the back-end weighted nature of our business, with 6% sequential top line growth and earnings per share up 28%.  We’re pleased with our recent progress driving efficiencies and containing costs which will allow us to emerge from these uncertain times even stronger, and have today introduced our 2026 Outlook reflecting further growth anticipated for both revenue and EPS.  This year we plan to expand our growing new business pipelines by capturing market share across our three attractive end markets with quality, innovative solutions, while leveraging our efficiencies and diverse supply base to further expand margins.  Enabled by our strong balance sheet, returning capital to shareholders through our attractive dividend even while investing for future growth remains a pillar of our strategy in our quest to further enhance long-term shareholder value.”

Fourth Quarter Results

For the fourth quarter ended December 31, 2025, net sales increased to $146.6 million compared to fourth quarter 2024 net sales of $145.4 million. Pretax income increased to $4.1 million compared to $2.5 million in the fourth quarter of 2024. Net income increased to $3.5 million or $0.23 per diluted share compared to $2.1 million or $0.13 per diluted share for the fourth quarter of 2024.

2026 Full-Year Outlook

The Company forecasts full-year 2026 net sales in the range of $572 million to $585 million, up from 2025 net sales of $566.2 million, and forecasts full-year earnings per diluted share in the range of $0.54 to $0.66, up from $0.46 in 2025. 

Webcast and Conference Call

The Company will host a webcast and conference call at 5:00 pm Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for International dialers. The Canadian Toll-Free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through March 17, 2026. To access the replay, dial 1-855-669-9658 in the United States and Canada or 1-412-317-0088 from international locations. Please reference conference number 6514610 for replay access.

Disclosure Regarding Forward Looking Statements

Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “project,” “potential,” or “plan” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release may include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short-term and long-term plans for cash (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.

Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; uncertainties related to tariffs, duties, trade wars and related matters, supply disruptions, inflationary environments (including with respect to shipping costs and the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (“U.S.” or “United States”) in which the Company’s customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the Company's ability to maintain effective internal control over financial reporting; and other factors described in the Company’s filings with the Securities and Exchange Commission, including those described in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 entitled "Risk Factors". Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

About Superior Group of Companies, Inc. (SGC):

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Branded Products, Healthcare Apparel and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

Investor Relations Contact:

Investors@SuperiorGroupOfCompanies.com 

Comparative figures are as follows:

 
 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except shares and per share data)
 
  Three Months Ended December 31,     Years Ended December 31,  
  2025     2024     2025     2024  
Net sales $ 146,575     $ 145,408     $ 566,184     $ 565,676  
                               
Costs and expenses:                              
Cost of goods sold   92,556       91,448       353,320       345,098  
Selling and administrative expenses   48,620       50,020       199,475       199,926  
Interest expense   1,270       1,461       5,143       6,358  
    142,446       142,929       557,938       551,382  
Income before income tax expense   4,129       2,479       8,246       14,294  
Income tax expense, net   666       390       1,246       2,290  
Net income $ 3,463     $ 2,089     $ 7,000     $ 12,004  
                               
Net income per share:                              
Basic $ 0.24     $ 0.13     $ 0.47     $ 0.75  
Diluted $ 0.23     $ 0.13     $ 0.46     $ 0.73  
                               
Weighted average shares outstanding during the period:                              
Basic   14,712,054       15,675,402       14,966,139       16,008,015  
Diluted   15,021,942       16,250,792       15,322,094       16,504,384  
                               
Cash dividends per common share $ 0.14     $ 0.14     $ 0.56     $ 0.56  


 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except share and par value data)
 
  December 31,  
  2025     2024  
ASSETS              
Current assets:              
Cash and cash equivalents $ 23,691     $ 18,766  
Accounts receivable   104,336       95,092  
Inventories   97,474       96,675  
Contract assets   48,903       51,688  
Prepaid expenses and other current assets   13,259       10,831  
Total current assets   287,663       273,052  
Property, plant and equipment, net   37,352       41,879  
Operating lease right-of-use assets   12,620       15,567  
Deferred tax asset   15,003       13,835  
Intangible assets, net   47,254       51,137  
Goodwill   2,583       2,304  
Other assets   19,369       17,360  
Total assets $ 421,844     $ 415,134  
               
LIABILITIES AND SHAREHOLDERS’ EQUITY              
Current liabilities:              
Accounts payable $ 48,343     $ 50,942  
Other current liabilities   53,041       44,367  
Current portion of long-term debt   6,563       5,625  
Current portion of acquisition-related contingent liabilities   -       814  
Total current liabilities   107,947       101,748  
Long-term debt   87,093       80,410  
Long-term pension liability   15,010       13,315  
Long-term acquisition-related contingent liabilities   826       935  
Long-term operating lease liabilities   7,939       10,486  
Other long-term liabilities   10,211       9,384  
Total liabilities   229,026       216,278  
Commitments and contingencies              
Shareholders’ equity:              
Preferred stock, $.001 par value - authorized 300,000 shares (none issued)   -       -  
Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding - 15,730,615 and 16,484,921 shares, respectively   16       16  
Additional paid-in capital   84,628       84,060  
Retained earnings   112,871       120,139  
Accumulated other comprehensive loss, net of tax   (4,697 )     (5,359 )
Total shareholders’ equity   192,818       198,856  
Total liabilities and shareholders’ equity $ 421,844     $ 415,134  


 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
 
  Years Ended December 31,  
  2025     2024  
CASH FLOWS FROM OPERATING ACTIVITIES              
Net income $ 7,000     $ 12,004  
Adjustments to reconcile net income to net cash provided by operating activities:              
Depreciation and amortization   12,355       13,185  
Inventory write-downs   2,252       2,423  
Credit loss expense   2,291       232  
Share-based compensation expense   5,263       4,270  
Deferred income tax benefit   (846 )     (1,581 )
Change in fair value of acquisition-related contingent liabilities   95       437  
Non-cash operating lease expense   2,948       2,337  
Change in fair value of written put options   -       653  
Other, net   299       507  
Changes in assets and liabilities, net of acquisition of businesses:              
Accounts receivable   (10,757 )     7,977  
Contract assets   3,045       (3,434 )
Inventories   (2,804 )     (1,031 )
Prepaid expenses and other current assets   (2,167 )     (2,375 )
Other assets   (2,076 )     (2,953 )
Accounts payable and other current liabilities   1,723       (403 )
Payment of acquisition-related contingent liabilities   (791 )     (686 )
Long-term pension liability   407       433  
Other long-term liabilities   1,472       1,433  
Net cash provided by operating activities   19,709       33,428  
               
CASH FLOWS FROM INVESTING ACTIVITIES              
Additions to property, plant and equipment   (3,947 )     (4,435 )
Acquisition of business   -       (4,000 )
Net cash used in investing activities   (3,947 )     (8,435 )
               
CASH FLOWS FROM FINANCING ACTIVITIES              
Borrowings under revolving lines of credit   95,000       47,000  
Payments under revolving lines of credit   (82,000 )     (50,000 )
Payment of term loan   (5,625 )     (4,687 )
Payment of cash dividends   (8,905 )     (9,284 )
Payment of acquisition-related contingent liabilities   (226 )     (897 )
Proceeds received on exercise of stock options   240       1,128  
Shares withheld for taxes   (162 )     (317 )
Common shares repurchased and retired   (10,136 )     (7,417 )
Net cash used in financing activities   (11,814 )     (24,474 )
               
Effect of currency exchange rates on cash   977       (1,649 )
Net increase (decrease) in cash and cash equivalents   4,925       (1,130 )
Cash and cash equivalents balance, beginning of year   18,766       19,896  
Cash and cash equivalents balance, end of year $ 23,691     $ 18,766  
               
Supplemental disclosure of cash flow information:              
Income taxes paid (refunded), net $ 1,623     $ 2,303  
Interest paid $ 5,663     $ 5,917  


 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
NON-GAAP FINANCIAL MEASURES
(Unaudited)
(In thousands, except shares and per share data)
 
  Three Months Ended December 31,   Years Ended December 31,  
  2025   2024   2025   2024  
Net income $ 3,463   $ 2,089   $ 7,000   $ 12,004  
Interest expense   1,270     1,461     5,143     6,358  
Income tax expense, net   666     390     1,246     2,290  
Depreciation and amortization   3,198     3,313     12,355     13,185  
Intangible assets impairment charge   -     -     -     260  
EBITDA(2) $ 8,597   $ 7,253   $ 25,744   $ 34,097  
EBITDA margin(2)   5.9 %   5.0 %   4.5 %   6.0 %


(2) EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, income tax expense, depreciation and amortization expense and impairment charges. EBITDA margin is defined as EBITDA divided by net sales. The Company believes EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences and (iii) asset base (depreciation and amortization and impairment charges). The Company uses EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. EBITDA is not a measure of financial performance under GAAP.  EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate EBITDA are significant components in understanding and assessing the Company’s results of operations. The presentation of the Company’s EBITDA may change from time to time, including as a result of changed business conditions, new accounting pronouncements or otherwise. If the presentation changes, the Company undertakes to disclose any change between periods and the reasons underlying that change. The Company’s EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate EBITDA in the same manner.

 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS
(Unaudited)
(In thousands)
 
  Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  
For the Three Months Ended December 31, 2025:                                              
Net sales $ 96,918     $ 28,830     $ 21,654     $ (827 )   $ -     $ 146,575  
Cost of goods sold   63,538       19,143       10,263       (388 )     -       92,556  
Gross margin   33,380       9,687       11,391       (439 )     -       54,019  
Selling and administrative expenses   23,714       10,167       9,569       (439 )     5,609       48,620  
Add: Depreciation and amortization   1,366       1,120       628       -       84       3,198  
Segment EBITDA(3) $ 11,032     $ 640     $ 2,450     $ -     $ (5,525 )   $ 8,597  
                                               
  Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  
For the Three Months Ended December 31, 2024:                                              
Net sales $ 92,403     $ 30,337     $ 23,527     $ (859 )   $ -     $ 145,408  
Cost of goods sold   61,057       20,110       10,667       (386 )     -       91,448  
Gross margin   31,346       10,227       12,860       (473 )     -       53,960  
Selling and administrative expenses   23,898       10,218       10,563       (473 )     5,814       50,020  
Add: Depreciation and amortization   1,435       1,055       722       -       101       3,313  
Intangible assets impairment charge   -       -       -       -       -       -  
Segment EBITDA(3) $ 8,883     $ 1,064     $ 3,019     $ -     $ (5,713 )   $ 7,253  


(3) Segment EBITDA is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income before income tax expense and excluded from Segment Adjusted EBITDA include: interest expense, depreciation and amortization expense, impairment charges and any other items not tied to the operational performance of the segment. Total Segment EBITDA is a non-GAAP financial measure. Please see reconciliation of Adjusted EBITDA included in the Non-GAAP Financial Measures table above.

 
SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS
(Unaudited)
(In thousands)
 
  Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  
For the Year Ended December 31, 2025:                                              
Net sales $ 361,134     $ 115,866     $ 92,520     $ (3,336 )   $ -     $ 566,184  
Cost of goods sold   237,422       73,904       43,540       (1,546 )     -       353,320  
Gross margin   123,712       41,962       48,980       (1,790 )     -       212,864  
Selling and administrative expenses   96,067       39,550       42,385       (1,790 )     23,263       199,475  
Add: Depreciation and amortization   5,637       3,718       2,650       -       350       12,355  
Segment EBITDA(3) $ 33,282     $ 6,130     $ 9,245     $ -     $ (22,913 )   $ 25,744  
                                               
  Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  
For the Year Ended December 31, 2024:                                              
Net sales $ 353,314     $ 119,191     $ 96,949     $ (3,778 )   $ -     $ 565,676  
Cost of goods sold   228,591       73,445       44,742       (1,680 )     -       345,098  
Gross margin   124,723       45,746       52,207       (2,098 )     -       220,578  
Selling and administrative expenses   94,384       41,149       42,999       (2,098 )     23,492       199,926  
Add: Depreciation and amortization   5,948       3,892       2,968       -       377       13,185  
Intangible assets impairment charge   -       260       -       -       -       260  
Segment EBITDA(3) $ 36,287     $ 8,749     $ 12,176     $ -     $ (23,115 )   $ 34,097  


(3) Segment EBITDA is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income before income tax expense and excluded from Segment Adjusted EBITDA include: interest expense, depreciation and amortization expense, impairment charges and any other items not tied to the operational performance of the segment. Total Segment EBITDA is a non-GAAP financial measure. Please see reconciliation of Adjusted EBITDA included in the Non-GAAP Financial Measures table above.


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions